The solubility enhancement generated by an amorphous phase over its crystalline counterpart is unaffected by the pH of the solution (at fixed ionic strength and temperature), even for a drug containing ionizable moieties, provided that both the ionized and neutral species generated through dissolution of the solids remain dissolved.
Keywords: advantage; amorphous; enhancement; pH; prediction; solubility.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.